The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the process of confirming a third Supreme Court nominee. The industry also rapidly responded to the unprecedented COVID-19 health crisis.
What changes are on the horizon for the medtech industry after the November 3rd election, whether with another Trump administration or a Biden administration? On Wednesday, October 28th, 2020, from 2:00 – 3:00 p.m. ET, Hyman, Phelps & McNamara, P.C. Director Jeffrey K. Shapiro will present at a webinar, titled “The Potential Life Sciences Implications of the Election.” Mr. Shapiro will cover the upcoming U.S. presidential election and its possible ramifications for the medical device industry.
You can register for this free webinar here.